Jamjoom Pharmaceuticals Factory Future Growth
Future criteria checks 4/6
Jamjoom Pharmaceuticals Factory is forecast to grow earnings and revenue by 14.5% and 12.7% per annum respectively. EPS is expected to grow by 14.5% per annum. Return on equity is forecast to be 23.5% in 3 years.
Key information
14.5%
Earnings growth rate
14.5%
EPS growth rate
Pharmaceuticals earnings growth | 17.3% |
Revenue growth rate | 12.7% |
Future return on equity | 23.5% |
Analyst coverage | Low |
Last updated | 25 Apr 2024 |
Recent future growth updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 1,669 | 459 | 443 | 486 | 2 |
12/31/2025 | 1,456 | 381 | 361 | 365 | 3 |
12/31/2024 | 1,275 | 312 | 270 | 335 | 3 |
12/31/2023 | 1,101 | 292 | 250 | 296 | N/A |
9/30/2023 | 1,090 | 280 | 153 | 205 | N/A |
6/30/2023 | 1,035 | 248 | 158 | 205 | N/A |
3/31/2023 | 975 | 212 | 107 | 163 | N/A |
12/31/2022 | 917 | 171 | 142 | 229 | N/A |
9/30/2022 | 930 | 199 | 96 | 209 | N/A |
6/30/2022 | 903 | 212 | 117 | 258 | N/A |
3/31/2022 | 822 | 188 | 92 | 240 | N/A |
12/31/2021 | 736 | 171 | 102 | 229 | N/A |
12/31/2020 | 805 | 207 | 98 | 262 | N/A |
12/31/2019 | 732 | 157 | 135 | 204 | N/A |
12/31/2018 | 701 | 151 | 66 | 113 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 4015's forecast earnings growth (14.5% per year) is above the savings rate (14.3%).
Earnings vs Market: 4015's earnings (14.5% per year) are forecast to grow faster than the SA market (6.5% per year).
High Growth Earnings: 4015's earnings are forecast to grow, but not significantly.
Revenue vs Market: 4015's revenue (12.7% per year) is forecast to grow faster than the SA market (-0.3% per year).
High Growth Revenue: 4015's revenue (12.7% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 4015's Return on Equity is forecast to be high in 3 years time (23.5%)